Read the interview of Olivier Devolder in La Libre and discover how N-SIDE solutions based on advanced analytics help companies to optimise their energy consumption and cost.read more
Boehringer Ingelheim Pharma has signed an agreement with N-SIDE to start a pilot project using N-SIDE’s risk-based production planning solution, CT-PRO. Boehringer Ingelheim joins other top pharmaceutical companies, such as Sanofi, who have recently partnered with N-SIDE for projects focused on production optimization. The project will evaluate optimization opportunities for the supply chain of two early phase clinical compounds […]read more
The Trends Business Tour honors Belgian companies that are innovative and sustainable. N-SIDE is proud to be part of the 5 nominees for Walloon Brabant, recognized for its solutions & services in the energy sector. The Trends Business Tour is an initiative of Trends-Tendances in partnership with BDO and ING. The Prize Ceremony Wallonia – Brussels will take place […]read more
This week-end, Philippe Chevalier, N-SIDE President of the Board of Directors and Jacques Parlongue, N-SIDE CEO were interviewed in l’Echo. While Philippe Chevalier described the start of N-SIDE in 2000 as a spin-off of UCL and ULg, Jacques Parlongue explained how this 5 million euros are going to boost the N-SIDE growth in the […]read more
Sanofi’s award-winning risk-based optimisation project published today in Clinical Trials Insight Magazine!
Sanofi’s supply team has successfully implemented the N-SIDE optimization solution, CT-FAST. The proven strategy led the team to become the proud winners of the 2016 Best Operational Excellence Award at the company’s Global R&D Awards. The implementation of N-SIDE’s CT-FAST solution resulted in the Sanofi clinical supply team moving towards an end-to-end optimisation approach and […]read more